Thomas Kazmirchuk on AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Thomas Kazmirchuk, Associate Research Fellow at Queen’s University, shared on LinkedIn:
”I am absolutely thrilled to share that my study on how we designed, screened, validated, and confirmed peptides with therapeutic and diagnostic utility in Platelet-type von Willebrand disease that was accepted in Blood Advances is now available online as a first edition!
This work brought together many disciplines from biochemistry, AI, hematology, and others to address a critical need in PT VWD and bleeding disorders as a whole.
Thank you to Ashkan Golshani, Dr. Maha Othman MD MSc PhD for your endless support during this project.
I would also like to thank our collaborators in Dr. Gresele’s lab at the University of Perugia for their assistance.
And thank you to the expert reviewers and of course the editorial staff at the American Society of Hematology’s Blood Advances.
The future is bright for hematology, medicine, and those with bleeding disorders.”
Read the full paper here.
Article: Developing an AI-Generated Peptide Targeting Platelet-type von Willebrand Disease
Authors: Thomas David Daniel Kazmirchuk, Jiashu Wang, Loredana Bury, Emanuela Falcinelli, Calvin Bradbury-Jost, Anastasiia Koziar, Mustafa Al-gafari, Sarah Takallou, William G Willmore, Frank Dehne, Paolo Gresele, Maha Othman, Ashkan Golshani
Stay updated on all scientific advances in the field of thrombosis with Hemostasis Today.
-
Sep 22, 2026, 04:15Wolfgang Miesbach: First AAV Gene Therapy Data in Adolescents With Haemophilia B
-
Sep 22, 2026, 04:03Emmanuel J Favaloro: 100 Years of VWD – A Special Virtual Issue
-
Sep 22, 2026, 03:31Mostafa Elshazly: How Is Humidification Used During Non Invasive Ventilation?
-
Sep 22, 2026, 03:05Sumyea Kabir: Jehovah’s Witnesses Update Their Position on Blood Components
-
Sep 22, 2026, 02:33Gerardo Moscatelli: The Spike Protein Cascade – From Endothelial Binding to Vascular Collapse
-
Sep 21, 2026, 20:56George Touma: ApoB Should Be Central to All Lipid Guidlines
-
Sep 21, 2026, 20:55Christopher Robinson: Obstetric Risks Are Seen at the Extremes of Birthweight
-
Sep 21, 2026, 20:54Emicizumab for Refractory GI Bleeding in Myeloma-Associated Acquired VWD – JTH
-
Sep 21, 2026, 20:52Ross Baker: ASH 2026 Guidelines on Iron Deficiency in HMB and Bleeding Disorders